Sat.Jun 21, 2025 - Fri.Jun 27, 2025

article thumbnail

Patients Don’t Want to Be Sold. They Want the Truth.

World of DTC Marketing

It’s a common misconception in pharma marketing that the goal is to “sell” a medication like you’d sell a soda or smartphone. But prescription drugs aren’t consumer goods—they are interventions in people’s health, often at critical moments in their lives. Patients aren’t looking for a sales pitch. They’re looking for trust, clarity, and reassurance that the treatment being suggested is truly proper for them.

article thumbnail

Novavax Sees Sanofi Vaccine Pact as Model for Future Deals, Some Going Beyond Infectious Disease

MedCity News

Novavax’s partnership with Sanofi allows the pharma giant to explore potential combinations of assets from both companies, and it’s a blueprint for the kinds of alliances the vaccine developer is pursuing. Rather than commercializing vaccines, Novavax aims to turn its research into business development deals, R&D executive Ruxandra Draghia-Akli said.

Pharma 336
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The FDA has removed the REMS requirements for currently approved BCMA- and CD19-directed CAR-T therapies and reduced certain post-infusion restrictions.

FDA 260
article thumbnail

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Pharma 147
article thumbnail

State of AI in Sales & Marketing 2025

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

article thumbnail

Do Physicians Want Updates On Clinical Trial?

World of DTC Marketing

Physicians’ engagement with clinical trial data about potential new drugs varies significantly based on factors such as their specialty, practice setting, interest, and time constraints. Some specialists do want updates, but they want data, not sales information slanted to the potential label. 1. Specialists vs. General Practitioners : Specialists (e.g., oncologists, neurologists, cardiologists) typically follow clinical trials closely because their practice heavily depends on emerging tr

article thumbnail

Vertex Pharma’s Type 1 Diabetes Cell Therapy Shows Potential to Achieve Insulin Independence

MedCity News

In Phase 1/2 results for 12 patients at least one year after receiving the cell therapy, zimislecel, Vertex Pharmaceuticals reported all participants achieved blood glucose in the target range and 10 of the 12 were free of exogenous insulin as of the data cutoff. Vertex expects to complete enrollment in the pivotal portion of the study this summer, paving the way for potential regulatory submissions next year.

More Trending

article thumbnail

How a Big Pharma veteran looks to stand out in biotech as a unique ‘drug hunter’

PharmaVoice

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.

Medicine 130
article thumbnail

What Makes a Great VP of Medical Affairs

World of DTC Marketing

In biotech and pharma, a strong Vice President (VP) of Medical Affairs can significantly impact a company’s path to clinical success and market credibility. This isn’t a figurehead position—it’s a linchpin role that bridges science, strategy, and storytelling. But what exactly makes a VP of Medical Affairs truly effective in this high-stakes space? Here’s a breakdown of the key traits, capabilities, and mindsets that set the best apart from the rest. 1.

Medical 170
article thumbnail

How Smarter Metrics Can Unlock AI’s Potential in Healthcare

MedCity News

Healthcare doesn’t reward shortcuts. It rewards outcomes. AI will play a critical role in shaping those outcomes — but only if leaders measure what truly matters. The best AI implementations elevate expertise, improve quality and create space for innovation. The post How Smarter Metrics Can Unlock AI’s Potential in Healthcare appeared first on MedCity News.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Roche has demonstrated the power of combining two of oncology's hottest modalities—bispecifics and antibody-drug conjugates—in a Lunsumio-Polivy regimen in large B-cell lymphoma.

220
220
article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Biopharma is on edge about NIH funding cuts and what the future holds for research

PharmaVoice

Proposed cuts to public funding for early science have led to an outcry in scientific circles. For biopharma leaders, the effects are still up in the air.

Biopharma 147
article thumbnail

Hiring Right: What Should a Biotech Startup Look for in a Chief Commercial Officer?

World of DTC Marketing

For biotech startups, success isn’t just about innovative science or groundbreaking technology. Equally crucial is having the strategic leadership to effectively commercialize innovations and transform scientific potential into market reality. Enter the Chief Commercial Officer (CCO)—a role that goes beyond just sales and marketing. A great CCO can shape your startup’s trajectory, ensure competitive positioning, and drive sustainable revenue growth.

article thumbnail

Beyond Technology: Aligning AI Tools with Systemic Change in Healthcare

MedCity News

The widespread investment in AI furthers economists’ optimism about a “roaring 20’s” of worker productivity on the horizon. However, this will not take place in health care without accompanying systemic and organizational actions that rethink what we financially incentivize, how we integrate new technologies, how we shift tasks, and how we prepare the workforce.

article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has demonstrated its effectiveness in another group of patients with the bleeding disorder.

Patients 223
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

How to Land Your Dream Medical Sales Job in 2025

Evolve Your Success

How to Land Your Dream Medical Sales Job in 2025. 1. Understand the Emerging Trends in Medical Sales To stand out as a medical sales candidate in 2025, it’s essential to understand the industry’s evolving trends. Some key areas to focus on include: Digital Health and Telemedicine : The rise of digital health tools and telemedicine means that sales reps will need to be knowledgeable about virtual healthcare solutions.

article thumbnail

Pharma Must Speak Up for Patient Safety

World of DTC Marketing

It’s a basic principle: the healthcare system exists to serve patients. Yet, astonishingly, the very institutions tasked with protecting and managing our healthcare can sometimes become a threat to patient safety. When incompetence infiltrates government agencies overseeing healthcare—through bureaucratic inertia, outdated policies, or poorly informed decisions—it’s patients who ultimately pay the price.

Safety 156
article thumbnail

More Than 50 Health Plans Commit to Simplifying Prior Authorization

MedCity News

Several insurers, such as UnitedHealthcare, Aetna and Cigna, pledged to improve prior authorization. These changes include streamlining decision timelines and increasing transparency. The post More Than 50 Health Plans Commit to Simplifying Prior Authorization appeared first on MedCity News.

Insurance 281
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

Amarin has forged a licensing deal with Italian pharma Recordati to commercialize its fish oil-derived heart pill Vascepa. Recordati will pay Amarin $25 million upfront to market the product to 59 European countries.

Pharma 198
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Vor Bio revives, thanks to $4bn+ licensing deal with RemeGen

pharmaphorum

Skip to main content Thursday 26 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Oncology -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -W

Media 82
article thumbnail

We’re at the Crossroads: Affordable Healthcare or Continued Suffering?

World of DTC Marketing

The American healthcare system stands at a pivotal intersection. On one path lies a vision of accessible, affordable care that prioritizes patients over profits. On the other hand, we persist in a status quo marked by soaring medical costs, heartbreaking choices between medication and necessities, and millions of people suffering because healthcare remains unaffordable.

article thumbnail

FDA Just Made Some Key Regulatory Changes to Make Cancer Cell Therapies More Accessible

MedCity News

The FDA has eliminated a safety monitoring requirement and eased certain restrictions that had been in place since CAR T-therapies first reached the market in 2017. The agency and financial analysts say the changes should improve patient access to these personalized cancer treatments. The post FDA Just Made Some Key Regulatory Changes to Make Cancer Cell Therapies More Accessible appeared first on MedCity News.

FDA 179
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

The FDA has blessed AstraZeneca and Daiichi Sankyo’s Datroway to treat patients with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer.

FDA 152
article thumbnail

The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report

ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!

article thumbnail

Could a vaccine adjuvant be protective against dementia?

pharmaphorum

Scientists behind a study suggesting GSK's RSV vaccine may be protective against dementia have said the adjuvant used in it may be responsible

93
article thumbnail

How AI and machine learning are transforming drug discovery

Pharmaceutical Technology

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

article thumbnail

What VCs Have Learned About Health Tech in the Public Markets

MedCity News

Two digital health companies have gone public this year: Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech in the public markets. The post What VCs Have Learned About Health Tech in the Public Markets appeared first on MedCity News.

Marketing 283
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

With a first-in-class approval in China, Eli Lilly’s GLP-1 development engine has delivered yet again on the obesity front—although local biopharma outfit Innovent Biologics will be the one to reap the rewards in the near term.

Biopharma 193
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Novo Nordisk's fling with Hims & Hers ends in a bust-up

pharmaphorum

The alliance between Novo Nordisk and telehealth firm Hims & Hers for the distribution of GLP-1 agonist weight-loss therapies has ended in acrimony.

article thumbnail

CDC panel, newly remade by RFK Jr., questions vaccine evidence

PharmaVoice

New members of the ACIP panel raised questions about the evidence supporting COVID vaccines, and signaled plans to look at other established shots, like those for measles and hepatitis B.

130
130
article thumbnail

Who is Speaking About AI at MedCity INVEST Digital Health in Dallas?

MedCity News

The conference will explore ethical considerations for AI in healthcare, how the healthcare industry is managing the teething challenges of AI “hallucinations”, practical concerns such as efficacy and ROI, and more. Register today! The post Who is Speaking About AI at MedCity INVEST Digital Health in Dallas? appeared first on MedCity News.

Ethics 249
article thumbnail

Fierce Pharma - Untitled Article

Fierce Pharma

UCB’s Fintepla has been approved to treat seizures associated with two epilepsy disorders and now has posted data that could pave the way for its use in another epilepsy condition. A phase 3 trial of Fintepla treating patients with the ultra-rare CDKL5 deficiency disorder has achieved its primary endpoint.

Patients 131
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten